Press Release
Category Added in a WPeMatico Campaign
-
Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
– Top-Line Results Anticipated in March 2026 – NEWTON, Mass., Sept. 10, 2025 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI),…
Read More » -
Xona and Orise Partner to Deliver Secure Remote Access for Regulated Manufacturing and Industrial Environments
Collaboration strengthens secure digital transformation across life sciences, food, and energy sectors with Zero-Trust access tailored for operational technology (OT)…
Read More »